Search research articles
Contact Us
Filters
Showing results (301-310 of 351) with videos related to
Page
of 36
Sort By:
Bone Marrow Transplantation
|
August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
Noureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
European Annals of Allergy and Clinical Immunology
|
April 30, 2020
Evaluation of two commercial peach extracts for skin prick testing in the diagnosis of hypersensitivity to lipid transfer protein. A multicenter study
R Asero, A Aruanno, M Bresciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2017
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
Nicolaus Kröger, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Bone Marrow Transplantation
|
August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
Tobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.
Bone Marrow Transplantation
|
April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
JAMA Network Open
|
August 5, 2024
COVID-19 Pandemic School Disruptions and Acute Mental Health in Children and Adolescents
Chiara Davico, Daniele Marcotulli, Giuseppe Abbracciavento, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT
Jan Styczynski, Gloria Tridello, Nina Knelange, et al.
Page
of 36
Search research articles
Search
Showing results (301-310 of 351) with videos related to
Sort By:
Page
of 36
Bone Marrow Transplantation
|
August 29, 2025
Conditioning intensity in myelodysplastic patients aged ≥ 50 years undergoing allogeneic hematopoietic cell transplantation (allo-HCT): a study on behalf of the chronic malignancies working party of the EBMT
Noureddine Henoun Loukili, Luuk Gras, Linda Koster, et al.
The Lancet. Haematology
|
July 2, 2026
Autologous and allogeneic haematopoietic cell transplantation in adult patients with Hodgkin lymphoma: recommendations from the EBMT Practice Harmonisation and Guidelines Committee and Lymphoma Working Party
Ali Bazarbachi, Ranjana Advani, Sairah Ahmed, et al.
European Annals of Allergy and Clinical Immunology
|
April 30, 2020
Evaluation of two commercial peach extracts for skin prick testing in the diagnosis of hypersensitivity to lipid transfer protein. A multicenter study
R Asero, A Aruanno, M Bresciani, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
May 3, 2017
Dose-Reduced Versus Standard Conditioning Followed by Allogeneic Stem-Cell Transplantation for Patients With Myelodysplastic Syndrome: A Prospective Randomized Phase III Study of the EBMT (RICMAC Trial)
Nicolaus Kröger, Simona Iacobelli, Georg-Nikolaus Franke, et al.
Bone Marrow Transplantation
|
August 19, 2025
Autologous haematopoietic stem cell transplantation for rheumatic diseases: best practice recommendations from the EBMT Practice Harmonization and Guidelines Committee
Tobias Alexander, Elisa Roldan, Nicoletta Del Papa, et al.
Bone Marrow Transplantation
|
April 23, 2022
Allogeneic hematopoietic cell transplantation in patients with therapy-related myeloid neoplasm after breast cancer: a study of the Chronic Malignancies Working Party of the EBMT
Mitja Nabergoj, Katya Mauff, Dietrich Beelen, et al.
Bone Marrow Transplantation
|
March 30, 2022
Prognostic value of a new clinically-based classification system in patients with CMML undergoing allogeneic HCT: a retrospective analysis of the EBMT-CMWP
Francesco Onida, Giulia Sbianchi, Aleksandar Radujkovic, et al.
JAMA Network Open
|
August 5, 2024
COVID-19 Pandemic School Disruptions and Acute Mental Health in Children and Adolescents
Chiara Davico, Daniele Marcotulli, Giuseppe Abbracciavento, et al.
Eclinicalmedicine
|
February 16, 2024
Innovative cellular therapies for autoimmune diseases: expert-based position statement and clinical practice recommendations from the EBMT practice harmonization and guidelines committee
Raffaella Greco, Tobias Alexander, Nicoletta Del Papa, et al.
Transplant Infectious Disease : an Official Journal of the Transplantation Society
|
March 2, 2026
Real-World Utilization Pattern and Outcomes of Letermovir in Adult Cytomegalovirus-Seropositive Allogeneic Hematopoietic Cell Transplant Recipients: An International Retrospective Study From the Infectious Diseases Working Party of EBMT
Jan Styczynski, Gloria Tridello, Nina Knelange, et al.
Page
of 36